“Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy”, FE, vol. 13, no. 3, pp. 121–131, Sep. 2012, doi: 10.7175/fe.v13i3.268.